KIDS OrthoPediatrics Corp

OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products

OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products

WARSAW, Ind., Dec. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics today announced that the OrthoPediatrics Specialty Bracing (OPSB™) division is expanding its product offering with the launch of two new products including the OPSB Sensor System and MOVE-D™.

The OPSB Sensor System represents the first sensor solution in OrthoPediatrics’ portfolio and an important step forward in the broader strategy around brace monitoring through the use of advanced sensor technology. For over 10 years, OrthoPediatrics’ wholly owned subsidiary, Boston Orthotics & Prosthetics has been at the forefront of utilizing thermal sensors in scoliosis braces based on published reports showing the direct correlation between brace wear time and success and improved wear time when a sensor is utilized in a brace. This game-changing Bluetooth connecting sensor automatically uploads data to an interactive App that awards stars and trophies for reaching wear time goals. The data is stored in a password protected cloud-based platform, allowing for remote monitoring by healthcare providers with downloadable reports.

In addition, OPSB also announced it has entered into license and supply and distribution agreements with Innovation Lab to bring the MOVE-D™ brace to market. Move-D™ is a simple and elegant mechanical elbow brace that stabilizes tremors in the dominant upper extremity to improve the performance of Activities of Daily Living (ADL) for pediatric patients with movement disorders.

OrthoPediatrics Specialty Bracing division President Joe Hauser commented, “We are excited that we continue to introduce new products that better support children and further expand the innovative solutions we offer through the OPSB channel. The team has been working with key opinion leaders from the surgeon community to identify new technologies that help children without going into the Operating Room, and both the OPSB Sensory System and MOVE-D represent opportunities to do so. Our partnership with Move-D represents the newest collaboration with other remarkable organizations focused on helping kids, advancing our shared commitment to advancing the field of pediatric orthopedics.”

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 70 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit For more information about the DF2® Brace and OrthoPediatrics’ Specialty Bracing portfolio, please visit .

Investor Contact

Philip Trip Taylor

Gilmartin Group



415-937-5406



EN
05/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OrthoPediatrics Corp

 PRESS RELEASE

OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results an...

OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance Second Quarter 2025 Revenue Surpasses $60 million for the First Time in Company History, and Increased Adjusted EBITDA by 58% year-over-year WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2025. Second Quarter 2025 and Business Highlights       He...

 PRESS RELEASE

OrthoPediatrics Corp. Announces Continued Expansion of Specialty Braci...

OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) division with multiple new clinics and entry into two new territories. The expansion of the OPSB division includes rapid expansion of greenfield clinic locations in California, Ohio, and ...

 PRESS RELEASE

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Ann...

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference WARSAW, Ind., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 45th Canaccord Genuity Annual Growth Conference, held in Boston, MA. Event: 45th Canaccord Genu...

 PRESS RELEASE

OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip Sys...

OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case WARSAW, Ind., Aug. 01, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the US launch and first surgical case of the new 3P™ Pediatric Plating Platform™ Hip System, used to treat proximal femur fractures and deformities. “The 3P Pediatric Plating Platform Hip System is an exceptional product that would not be possible without our remarkable desi...

 PRESS RELEASE

OrthoPediatrics Corp. to Report Second Quarter Financial Results on Au...

OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025 WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2025 financial results on August 5, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 5, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch